Other
How MDMA is being used to treat PTSD
- Approximately 22 U.S. military veterans die by suicide daily, with an estimated 20% of the veteran population suffering from Post-Traumatic Stress Disorder (PTSD).
- Total Americans affected by PTSD is estimated at 8 million, a public health crisis costing the Department of Veterans Affairs roughly $400 million annually.
- Standard pharmacological treatments for PTSD show success in only 20% of cases, often requiring long-term daily use that flattens emotional response.
- MDMA (3,4-methylenedioxymethamphetamine), the active ingredient in ecstasy, has been designated a "breakthrough therapy" by the FDA for PTSD treatment.
- Clinical trials indicate that over 60% of patients no longer met clinical criteria for PTSD after receiving MDMA-assisted therapy.
- The drug functions by flooding the brain with hormones and neurotransmitters that evoke trust and well-being, effectively disconnecting the amygdala's fear response during trauma processing.
- John Lubecki, a Iraq War veteran and trial subject, reported the treatment as his "greatest therapeutic experience" after previous attempts at suicide, including overdoses and self-harm, failed for eight years.
- Lubecki described the sensory experience of the drug as a gradual rise over 30–40 minutes involving anxiety and geometric patterns, ultimately facilitating the discussion of trauma without panic attacks.
- The treatment protocol involves administering MDMA only three times, spaced one month apart, accompanied by 12 non-drug psychotherapy sessions lasting approximately eight hours each.
- Rick Doblin, a researcher leading the effort since the 1980s, notes the drug allows patients to re-examine traumatic memories in a state of safety, likening the sensation to "doing therapy while being hugged by everyone who loves you in a bathtub full of puppies."
- A small non-profit is funding the final stage of FDA approval trials, which will involve 300 subjects, because MDMA is not patentable and thus lacks commercial appeal for major pharmaceutical companies.
- MDMA therapy has moderate addiction risks but is considered less harmful than alcohol or tobacco; it was previously used in psychotherapy in the 1970s before being illegalized in the 1980s.
- If the current trials are successful, the FDA approval could transform MDMA from an illicit party drug into a regulated medicine for treating PTSD.
- Veterans report that the treatment prevents a "life cut short," enabling them to survive long-term interactions with family and avoid predeceasing their children and grandchildren.
- Researchers highlight that PTSD affects not only those in direct combat but also soldiers subjected to constant fear from indirect threats, such as repeated mortar fire on a base.